How do PK and PD integrate in PK/PD models to inform dosing decisions?

How do PK and PD integrate in PK/PD models to inform dosing decisions?

• A. PK describes drug exposure over time; PD links exposure to effect; together they predict efficacy and toxicity at given doses.
• B. PD describes drug exposure over time; PK links exposure to effect.
• C. PK and PD are unrelated in dose planning.
• D. PK predicts safety only; PD predicts pharmacokinetics.

Answer: (A)

The key idea is that dosing decisions come from linking how the body handles a drug to how the drug's concentration relates to its effect. Pharmacokinetics describes how the drug concentration changes over time in the body—through absorption, distribution, metabolism, and elimination. Pharmacodynamics describes what those concentrations do to the body—the relationship between exposure and the pharmacologic response, including both efficacy and toxicity. When you combine these, a dose produces a concentration-time profile (PK), and that profile maps to a response through the concentration–effect relationship (PD). This lets you predict how a given dose will perform in terms of efficacy and safety, guiding dose and dosing interval choices to achieve the desired therapeutic effect while minimizing adverse effects. The other options misplace these roles or claim PK and PD are unrelated or only about safety, which doesn’t reflect how PK/PD modeling informs dosing.

The key idea is that dosing decisions come from linking how the body handles a drug to how the drug's concentration relates to its effect. Pharmacokinetics describes how the drug concentration changes over time in the body—through absorption, distribution, metabolism, and elimination. Pharmacodynamics describes what those concentrations do to the body—the relationship between exposure and the pharmacologic response, including both efficacy and toxicity. When you combine these, a dose produces a concentration-time profile (PK), and that profile maps to a response through the concentration–effect relationship (PD). This lets you predict how a given dose will perform in terms of efficacy and safety, guiding dose and dosing interval choices to achieve the desired therapeutic effect while minimizing adverse effects. The other options misplace these roles or claim PK and PD are unrelated or only about safety, which doesn’t reflect how PK/PD modeling informs dosing.